Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Ductal, Breast | 11 | 2023 | 1099 | 1.470 |
Why?
|
Breast Neoplasms | 49 | 2025 | 21206 | 1.310 |
Why?
|
Receptor, erbB-2 | 20 | 2025 | 2603 | 1.300 |
Why?
|
Li-Fraumeni Syndrome | 3 | 2020 | 117 | 0.770 |
Why?
|
DNA Copy Number Variations | 4 | 2024 | 2048 | 0.720 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 5 | 2023 | 934 | 0.700 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2024 | 2521 | 0.660 |
Why?
|
Polymorphism, Single-Stranded Conformational | 5 | 2005 | 325 | 0.530 |
Why?
|
Professional Autonomy | 1 | 2017 | 172 | 0.500 |
Why?
|
Breast | 7 | 2024 | 1976 | 0.440 |
Why?
|
Nurse Practitioners | 1 | 2017 | 271 | 0.440 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2017 | 526 | 0.440 |
Why?
|
Genes, ras | 4 | 2005 | 663 | 0.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3671 | 0.380 |
Why?
|
Receptors, Estrogen | 10 | 2025 | 2253 | 0.350 |
Why?
|
Mutation | 16 | 2024 | 30238 | 0.350 |
Why?
|
BRCA1 Protein | 5 | 2024 | 1155 | 0.340 |
Why?
|
Breast Neoplasms, Male | 3 | 2020 | 213 | 0.300 |
Why?
|
Genes, p53 | 3 | 2012 | 714 | 0.290 |
Why?
|
BRCA2 Protein | 2 | 2024 | 802 | 0.280 |
Why?
|
DNA Mutational Analysis | 6 | 2015 | 4120 | 0.270 |
Why?
|
Pathology, Clinical | 2 | 2024 | 375 | 0.260 |
Why?
|
Carcinoma, Lobular | 2 | 2022 | 480 | 0.260 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 3 | 2018 | 267 | 0.260 |
Why?
|
Polymerase Chain Reaction | 4 | 2005 | 6082 | 0.250 |
Why?
|
Biopsy, Needle | 2 | 2017 | 1622 | 0.240 |
Why?
|
Microdissection | 1 | 2005 | 150 | 0.230 |
Why?
|
Aniline Compounds | 2 | 2020 | 1094 | 0.230 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1105 | 0.220 |
Why?
|
Histocytochemistry | 1 | 2024 | 699 | 0.210 |
Why?
|
Receptors, Progesterone | 5 | 2020 | 1160 | 0.200 |
Why?
|
Loss of Heterozygosity | 1 | 2024 | 663 | 0.200 |
Why?
|
Immunoconjugates | 2 | 2020 | 975 | 0.200 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2017 | 1134 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2020 | 11878 | 0.190 |
Why?
|
Female | 64 | 2025 | 397192 | 0.190 |
Why?
|
Immunohistochemistry | 10 | 2024 | 11095 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9419 | 0.190 |
Why?
|
SOXC Transcription Factors | 1 | 2020 | 41 | 0.180 |
Why?
|
bcl-X Protein | 2 | 2020 | 412 | 0.180 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 3948 | 0.180 |
Why?
|
Lasers | 1 | 2005 | 952 | 0.180 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2022 | 590 | 0.170 |
Why?
|
Primary Health Care | 1 | 2017 | 4746 | 0.170 |
Why?
|
Sulfonamides | 2 | 2020 | 1982 | 0.170 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2022 | 506 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2020 | 5341 | 0.170 |
Why?
|
Gene Dosage | 1 | 2024 | 1219 | 0.170 |
Why?
|
Ketones | 1 | 2020 | 183 | 0.160 |
Why?
|
Furans | 1 | 2020 | 199 | 0.160 |
Why?
|
Humans | 82 | 2025 | 768166 | 0.160 |
Why?
|
Receptor, erbB-3 | 1 | 2020 | 142 | 0.160 |
Why?
|
Carcinoma | 3 | 2019 | 2332 | 0.160 |
Why?
|
Mammary Glands, Human | 1 | 2020 | 202 | 0.160 |
Why?
|
Smad4 Protein | 1 | 2019 | 193 | 0.150 |
Why?
|
Antibodies, Monoclonal | 4 | 2020 | 9263 | 0.150 |
Why?
|
Pattern Recognition, Automated | 1 | 2024 | 993 | 0.150 |
Why?
|
Nephroma, Mesoblastic | 1 | 2017 | 25 | 0.150 |
Why?
|
Tumor Escape | 1 | 2020 | 372 | 0.150 |
Why?
|
Heterozygote | 1 | 2024 | 2798 | 0.150 |
Why?
|
Cadherins | 2 | 2022 | 905 | 0.140 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2954 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2023 | 8647 | 0.140 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3620 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2020 | 1406 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2022 | 565 | 0.140 |
Why?
|
Germ-Line Mutation | 3 | 2019 | 1885 | 0.130 |
Why?
|
Paclitaxel | 3 | 2019 | 1733 | 0.130 |
Why?
|
Integrins | 1 | 2020 | 842 | 0.130 |
Why?
|
Nipples | 1 | 2018 | 227 | 0.130 |
Why?
|
Fibrosarcoma | 1 | 2017 | 313 | 0.130 |
Why?
|
Cell Line, Tumor | 12 | 2020 | 17140 | 0.130 |
Why?
|
Pathology, Surgical | 1 | 2016 | 148 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2019 | 1353 | 0.120 |
Why?
|
Antineoplastic Agents | 4 | 2022 | 13676 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 581 | 0.120 |
Why?
|
Bile Duct Neoplasms | 1 | 2000 | 614 | 0.120 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 66 | 0.120 |
Why?
|
Menopause | 1 | 2022 | 1656 | 0.110 |
Why?
|
Middle Aged | 31 | 2025 | 223492 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5703 | 0.110 |
Why?
|
PTEN Phosphohydrolase | 1 | 2020 | 1120 | 0.110 |
Why?
|
Cytodiagnosis | 1 | 2017 | 452 | 0.110 |
Why?
|
Organoids | 1 | 2020 | 743 | 0.110 |
Why?
|
Azepines | 1 | 2016 | 329 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2020 | 2062 | 0.110 |
Why?
|
Exons | 4 | 2010 | 2394 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2020 | 3611 | 0.110 |
Why?
|
Mucin-1 | 1 | 2017 | 537 | 0.100 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2016 | 354 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1997 | 0.100 |
Why?
|
Genes, erbB-2 | 1 | 2013 | 162 | 0.100 |
Why?
|
Epithelial Cells | 1 | 2024 | 3703 | 0.100 |
Why?
|
Carcinoma, Ductal | 1 | 2013 | 97 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 1667 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1898 | 0.100 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1027 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1074 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2001 | 1183 | 0.100 |
Why?
|
Cytoskeletal Proteins | 1 | 1998 | 1327 | 0.100 |
Why?
|
Brain Neoplasms | 2 | 2025 | 9118 | 0.100 |
Why?
|
src-Family Kinases | 1 | 2014 | 539 | 0.100 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1613 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3514 | 0.090 |
Why?
|
Prognosis | 10 | 2025 | 30010 | 0.090 |
Why?
|
Cell Lineage | 1 | 2020 | 2575 | 0.090 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2011 | 95 | 0.090 |
Why?
|
Codon | 3 | 2001 | 599 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2017 | 1613 | 0.090 |
Why?
|
Immunotherapy | 3 | 2022 | 4755 | 0.090 |
Why?
|
Adult | 24 | 2025 | 223646 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 904 | 0.090 |
Why?
|
Aged | 24 | 2025 | 171504 | 0.090 |
Why?
|
Doxorubicin | 1 | 2017 | 2234 | 0.090 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 519 | 0.090 |
Why?
|
Fibroblasts | 1 | 2020 | 4176 | 0.080 |
Why?
|
Ubiquitination | 1 | 2014 | 1009 | 0.080 |
Why?
|
Lipids | 2 | 2018 | 3343 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2001 | 2541 | 0.080 |
Why?
|
Mice | 15 | 2022 | 82029 | 0.080 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 306 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 3445 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3772 | 0.080 |
Why?
|
Neoplasms | 4 | 2024 | 22371 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1406 | 0.080 |
Why?
|
Phosphoproteins | 1 | 1998 | 2451 | 0.080 |
Why?
|
Phenotype | 2 | 2020 | 16726 | 0.080 |
Why?
|
Medical Errors | 1 | 2016 | 1260 | 0.080 |
Why?
|
Trans-Activators | 1 | 1998 | 2857 | 0.070 |
Why?
|
DNA, Neoplasm | 3 | 2002 | 1744 | 0.070 |
Why?
|
Cell Proliferation | 6 | 2022 | 10474 | 0.070 |
Why?
|
Colorectal Neoplasms | 3 | 2005 | 6974 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4648 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2907 | 0.070 |
Why?
|
Animals | 20 | 2022 | 169246 | 0.070 |
Why?
|
Transcription Factors | 4 | 2023 | 12168 | 0.070 |
Why?
|
Stem Cells | 1 | 2020 | 3537 | 0.070 |
Why?
|
Aged, 80 and over | 14 | 2020 | 59629 | 0.070 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 2043 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2830 | 0.070 |
Why?
|
Palliative Care | 2 | 2020 | 3643 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2885 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2176 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 928 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2019 | 3556 | 0.070 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9538 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2025 | 81762 | 0.060 |
Why?
|
Lymph Nodes | 3 | 2021 | 3474 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 18065 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6526 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1901 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2010 | 788 | 0.060 |
Why?
|
Phosphorylation | 5 | 2016 | 8317 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2474 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5889 | 0.060 |
Why?
|
Signal Transduction | 4 | 2020 | 23645 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2020 | 2014 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2023 | 36 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10266 | 0.060 |
Why?
|
Survival Rate | 4 | 2025 | 12840 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2568 | 0.060 |
Why?
|
Proteomics | 3 | 2022 | 3912 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2235 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 905 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2000 | 5446 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1837 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 1996 | 0.050 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6847 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13014 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2002 | 125 | 0.050 |
Why?
|
Ploidies | 1 | 2002 | 287 | 0.050 |
Why?
|
Genetic Markers | 3 | 2003 | 2603 | 0.050 |
Why?
|
Genes, Tumor Suppressor | 2 | 2015 | 1062 | 0.050 |
Why?
|
Mice, SCID | 2 | 2019 | 2627 | 0.050 |
Why?
|
Mice, Obese | 1 | 2022 | 417 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2040 | 0.050 |
Why?
|
Neoplasm Staging | 4 | 2020 | 11244 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5804 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2020 | 2457 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2022 | 748 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2540 | 0.050 |
Why?
|
Tumor Burden | 2 | 2019 | 1906 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4282 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2022 | 273 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2002 | 392 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2025 | 39348 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 13090 | 0.040 |
Why?
|
DNA | 3 | 2022 | 7214 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 812 | 0.040 |
Why?
|
Apoptosis | 3 | 2020 | 9523 | 0.040 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 355 | 0.040 |
Why?
|
Phosphatidate Phosphatase | 1 | 1999 | 21 | 0.040 |
Why?
|
Neoplasm Proteins | 2 | 2004 | 3603 | 0.040 |
Why?
|
Dissection | 1 | 2001 | 299 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2017 | 5902 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2004 | 872 | 0.040 |
Why?
|
Diamines | 1 | 2019 | 60 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 72 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2018 | 1534 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 570 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14729 | 0.040 |
Why?
|
Abscess | 1 | 2002 | 606 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 710 | 0.040 |
Why?
|
Glycolipids | 1 | 1999 | 205 | 0.040 |
Why?
|
Mastectomy | 2 | 2019 | 1861 | 0.040 |
Why?
|
Esters | 1 | 1999 | 212 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 866 | 0.040 |
Why?
|
Mind-Body Therapies | 1 | 2021 | 294 | 0.040 |
Why?
|
alpha Catenin | 1 | 1998 | 37 | 0.040 |
Why?
|
Catenins | 1 | 1998 | 44 | 0.040 |
Why?
|
Genotype | 3 | 2019 | 13045 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2002 | 1743 | 0.040 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2019 | 252 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2019 | 506 | 0.040 |
Why?
|
Research Design | 1 | 2013 | 6211 | 0.040 |
Why?
|
Membrane Proteins | 3 | 2004 | 7876 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 2 | 2019 | 2810 | 0.040 |
Why?
|
Sphingolipids | 1 | 1999 | 178 | 0.040 |
Why?
|
Protein Binding | 3 | 2016 | 9343 | 0.040 |
Why?
|
Pyrophosphatases | 1 | 1998 | 142 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2018 | 247 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1999 | 414 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2020 | 697 | 0.040 |
Why?
|
Lymphocytes | 2 | 2021 | 2614 | 0.030 |
Why?
|
Cysts | 1 | 2002 | 685 | 0.030 |
Why?
|
Carcinoma, Papillary | 1 | 2002 | 793 | 0.030 |
Why?
|
Recurrence | 3 | 2019 | 8509 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 693 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2018 | 350 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2017 | 313 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2019 | 386 | 0.030 |
Why?
|
Risk Management | 1 | 2020 | 558 | 0.030 |
Why?
|
Genes, Fungal | 1 | 1998 | 440 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 3800 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5926 | 0.030 |
Why?
|
Point Mutation | 1 | 2001 | 1596 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 31 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1820 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7454 | 0.030 |
Why?
|
Culture Media | 1 | 2018 | 898 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2004 | 1424 | 0.030 |
Why?
|
Phosphates | 1 | 1999 | 765 | 0.030 |
Why?
|
Phosphoserine | 1 | 2016 | 204 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2016 | 121 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2230 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2464 | 0.030 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2014 | 15 | 0.030 |
Why?
|
Thyroid Nodule | 1 | 2002 | 767 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2002 | 1627 | 0.030 |
Why?
|
Genome | 1 | 2003 | 1754 | 0.030 |
Why?
|
Oleic Acid | 1 | 2014 | 91 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2016 | 1142 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2429 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9561 | 0.030 |
Why?
|
Nanomedicine | 1 | 2017 | 292 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2107 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 1998 | 564 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 231 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2023 | 2059 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2002 | 6395 | 0.030 |
Why?
|
Cell Cycle | 1 | 2022 | 2932 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 819 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1801 | 0.030 |
Why?
|
Rwanda | 1 | 2016 | 671 | 0.030 |
Why?
|
Base Sequence | 2 | 2002 | 12421 | 0.030 |
Why?
|
Exercise | 2 | 2021 | 5955 | 0.030 |
Why?
|
Melanocytes | 1 | 2017 | 509 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 404 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 192 | 0.030 |
Why?
|
Young Adult | 5 | 2020 | 60066 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2403 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2019 | 716 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1596 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1712 | 0.030 |
Why?
|
Ferric Compounds | 1 | 2014 | 376 | 0.030 |
Why?
|
beta Catenin | 1 | 1998 | 1047 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2000 | 1767 | 0.030 |
Why?
|
Nanotechnology | 1 | 2018 | 714 | 0.030 |
Why?
|
Bone Marrow | 1 | 2002 | 2935 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2022 | 2631 | 0.020 |
Why?
|
Exercise Therapy | 1 | 2019 | 939 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4860 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20227 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 957 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 2 | 2003 | 2682 | 0.020 |
Why?
|
Male | 11 | 2024 | 364719 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 1196 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1778 | 0.020 |
Why?
|
United States | 2 | 2017 | 73039 | 0.020 |
Why?
|
Rats | 4 | 2022 | 23760 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2022 | 8128 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4352 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2744 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13671 | 0.020 |
Why?
|
Cohort Studies | 4 | 2020 | 41754 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2258 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4249 | 0.020 |
Why?
|
Carboplatin | 1 | 2013 | 797 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 4528 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 17622 | 0.020 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 498 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2013 | 1903 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1110 | 0.020 |
Why?
|
Mice, Nude | 1 | 2016 | 3623 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4206 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2003 | 6124 | 0.020 |
Why?
|
Oncogenes | 1 | 2015 | 1234 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6316 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2002 | 2360 | 0.020 |
Why?
|
Pyrazoles | 1 | 2019 | 2028 | 0.020 |
Why?
|
Metabolomics | 1 | 2018 | 1674 | 0.020 |
Why?
|
Necrosis | 2 | 2003 | 1616 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1998 | 1839 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 747 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 89169 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2622 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4912 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9613 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1606 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 13421 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2982 | 0.020 |
Why?
|
Fatty Acids | 1 | 2014 | 1812 | 0.020 |
Why?
|
Databases, Factual | 1 | 2001 | 8080 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5799 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 6020 | 0.020 |
Why?
|
Muscles | 1 | 1990 | 1582 | 0.020 |
Why?
|
Registries | 1 | 2001 | 8375 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4283 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5210 | 0.010 |
Why?
|
Cloning, Molecular | 2 | 2002 | 4168 | 0.010 |
Why?
|
Genetic Variation | 1 | 2020 | 6611 | 0.010 |
Why?
|
Genetic Testing | 1 | 2017 | 3591 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 22379 | 0.010 |
Why?
|
Chromatin | 1 | 2016 | 2981 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2003 | 125 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3620 | 0.010 |
Why?
|
Nanoparticles | 1 | 2014 | 1985 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4446 | 0.010 |
Why?
|
Polyploidy | 1 | 2003 | 120 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11669 | 0.010 |
Why?
|
Time Factors | 2 | 2002 | 40218 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3833 | 0.010 |
Why?
|
Antioxidants | 1 | 1990 | 1673 | 0.010 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2002 | 62 | 0.010 |
Why?
|
Genome, Fungal | 1 | 2003 | 203 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7608 | 0.010 |
Why?
|
DNA, Fungal | 1 | 2003 | 275 | 0.010 |
Why?
|
Aging | 2 | 1991 | 8744 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2003 | 1305 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19015 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3968 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2003 | 453 | 0.010 |
Why?
|
Lipid Peroxides | 2 | 1991 | 74 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2003 | 630 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 1084 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2002 | 228 | 0.010 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2003 | 340 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 30256 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13490 | 0.010 |
Why?
|
Valine | 1 | 2001 | 410 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3503 | 0.010 |
Why?
|
Oxygen | 1 | 1991 | 4270 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1989 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16045 | 0.010 |
Why?
|
Automation | 1 | 2001 | 589 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 74944 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54926 | 0.010 |
Why?
|
Myocardium | 1 | 1991 | 4788 | 0.010 |
Why?
|
Melanoma | 1 | 2017 | 5706 | 0.010 |
Why?
|
Hydrolysis | 1 | 1999 | 646 | 0.010 |
Why?
|
Tamoxifen | 1 | 2002 | 966 | 0.010 |
Why?
|
Oncogene Proteins | 1 | 2002 | 717 | 0.010 |
Why?
|
Spodoptera | 1 | 1998 | 140 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 492 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1998 | 455 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 1999 | 571 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 424 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26422 | 0.010 |
Why?
|
Cell Line | 2 | 2003 | 15597 | 0.010 |
Why?
|
Lysophospholipids | 1 | 1999 | 338 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18349 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65371 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15869 | 0.010 |
Why?
|
Rabbits | 1 | 2002 | 4772 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 10399 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36535 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1999 | 1751 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4580 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42669 | 0.010 |
Why?
|
Liver | 1 | 1990 | 7577 | 0.010 |
Why?
|
Age Factors | 2 | 2003 | 18412 | 0.010 |
Why?
|
Mutagenesis | 1 | 1998 | 1228 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1999 | 3590 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2002 | 2433 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 2819 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2001 | 2592 | 0.010 |
Why?
|
Kinetics | 1 | 1999 | 6329 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8542 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1999 | 3740 | 0.010 |
Why?
|
Rats, Inbred WF | 1 | 1990 | 140 | 0.010 |
Why?
|
Citrate (si)-Synthase | 1 | 1990 | 48 | 0.010 |
Why?
|
Gene Deletion | 1 | 1998 | 2675 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1998 | 2914 | 0.010 |
Why?
|
Catalase | 1 | 1990 | 215 | 0.010 |
Why?
|
Cell Membrane | 1 | 1999 | 3655 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1990 | 412 | 0.000 |
Why?
|
Glutathione Peroxidase | 1 | 1990 | 259 | 0.000 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1990 | 209 | 0.000 |
Why?
|
Survival Analysis | 1 | 2001 | 10101 | 0.000 |
Why?
|
Child | 1 | 2017 | 80917 | 0.000 |
Why?
|
Glutathione Transferase | 1 | 1990 | 564 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12077 | 0.000 |
Why?
|
Superoxide Dismutase | 1 | 1990 | 596 | 0.000 |
Why?
|
Glycolysis | 1 | 1991 | 837 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36743 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 2001 | 12543 | 0.000 |
Why?
|
Organ Size | 1 | 1991 | 2267 | 0.000 |
Why?
|
Calcium | 1 | 1999 | 5792 | 0.000 |
Why?
|
Muscle Proteins | 1 | 1991 | 1165 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1991 | 2227 | 0.000 |
Why?
|
Heart | 1 | 1991 | 4446 | 0.000 |
Why?
|